entity

BBB integrity

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about BBB integrity: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

11Connections

5Hypotheses

5Analyses

0Outgoing

11Incoming

0Experiments

7Debates

No AI portrait yet

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (11)

Source	Relation	Type	Str
QAlb	biomarker_for	biomarker	0.90
pericyte-specific PDGFRβ signaling	regulates	process	0.70
Liproxstatin-1	protective_against	drug	0.70
Liproxstatin-1	protects_against	drug	0.70
endothelial cells	modulates	cell_type	0.70
astrocyte end-feet	regulates	cell_type	0.70
LRP1	associated_with	gene	0.70
APOE4	impairs	gene	0.70
PDGFRβ signaling	regulates	pathway	0.70
MMP-9	inhibits	enzyme	0.50
Claudin-5	protects	protein	0.50

Targeting Hypotheses (5)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
BBB Integrity Loss Defines Absolute Therapeutic Window Closu	0.660	neurodegeneration	What is the optimal therapeutic window f
Vascular and Perivascular Cell Type Vulnerability: BBB Integ	0.566	neurodegeneration	Cell type vulnerability debate in Alzhei
CSF p-tau217 Normalization Requires Intact Synaptic Function	0.515	neurodegeneration	-
HBOT at 1.5 ATA for 90 days restores BBB integrity by upregu	0.460	neurodegeneration	What are the optimal oxygen pressure, du
HTR2A-Mediated MMP-9 Suppression Preserves BBB Integrity at	0.425	-	What is the minimum effective dose of tr

Mentioning Analyses (5)

Scientific analyses that reference this entity

What blood-brain barrier permeability changes serve as early biomarkers for neur

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.940

Can ferroptosis inhibitors prevent BBB disruption and edema formation after card

neurodegeneration | 2026-04-25 | 7 hypotheses Top: 0.760

Multi-modal Biomarker Panel Design for Early AD Detection

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.559

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

neurodegeneration | 2026-04-16 | 7 hypotheses Top: 0.806

What is the optimal therapeutic window for microglial reprogramming before irrev

neurodegeneration | 2026-04-06 | 7 hypotheses Top: 0.735

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (7)

Multi-agent debates referencing this entity

What blood-brain barrier permeability changes serve as early biomarkers for neur

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

Can ferroptosis inhibitors prevent BBB disruption and edema formation after card

closed · Rounds: 4 · Score: 0.73 · 2026-04-25

Should PEA-PPARA endocannabinoid signaling be prioritized as a therapeutic strat

closed · Rounds: 4 · Score: 0.76 · 2026-04-23

Multiple hypotheses assumed microglia could be restored to homeostatic states, b

closed · Rounds: 4 · Score: 0.63 · 2026-04-22

Can a multi-modal biomarker panel combining plasma proteins, neuroimaging featur

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Should clinical practice adopt multi-modal biomarker panels now, or wait for sin

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

closed · Rounds: 7 · Score: 0.87 · 2026-04-16

Related Research

Hypotheses and analyses mentioning BBB integrity in their description or question text

No additional research found